title: [Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
authors: Y
authors: Y
authors: Murakawa
authors: M
authors: M
authors: Tsutsumi
authors: N
authors: N
authors: Murata
authors: Y
authors: Y
authors: Sasaki
authors: T
authors: T
authors: Tsujiuchi
authors: K
authors: K
authors: Mikasa
authors: N
authors: N
authors: Narita
authors: Y
authors: Y
authors: Konishi
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000139:chemically induced / Q000517:prevention & control*; D002908:Chronic Disease; D017291:Clarithromycin / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D017308:Etodolac / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D009602:Nitrosamines; D011014:Pneumonia / Q000139:chemically induced / Q000517:prevention & control; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000900:Anti-Bacterial Agents; D016861:Cyclooxygenase Inhibitors; D009602:Nitrosamines; D017308:Etodolac; C012457:diisopropanolnitrosamine; D017291:Clarithromycin